What it sells
Automates drug discovery.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHeads of R&D / clinical development at pharma and biotech (hypothesis).
Trigger: what makes them buy now?
Insights are siloed across teams and tools, so decisions in drug development are not made on the full evidence base.
Workflow: what inputs become what output?
Unifies evidence and reasoning across teams and tools, adds traceable decision workflows and learns from the team's work.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-05-26 | Seed | $12M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.